Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.
Article
PubMed
Google Scholar
World Health Organisation. Noncommunicable diseases country profiles 2014. http://apps.who.int/iris/bitstream/10665/128038/1/9789241507509_eng.pdf (2014). Accessed 28 May 2017.
Bonnett B, Egenvall A, Hedhammar A, Olson P. Mortality in over 350,000 insured Swedish dogs from 1995–2000: I. Breed-, gender-, age- and cause-specific rates. Acta Vet Scand. 2005;46:105–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
DeVita VT, Chu E. A history of cancer chemotherapy. Cancer Res. 2008;68:8643–53.
Article
CAS
PubMed
Google Scholar
Grüntzig K, Graf R, Hässig M, Welle M, Meier D, Lott G, Erni D, Schenker NS, Guscetti F, Boo G, et al. The swiss canine cancer registry: a retrospective study on the occurrence of tumours in dogs in Switzerland from 1955 to 2008. J Comp Pathol. 2015;152:161–71.
Article
PubMed
Google Scholar
Ranieri G, Gadaleta CD, Patruno R, Zizzo N, Daidone MG, Hansson MG, Paradiso A, Ribatti D. A model of study for human cancer: spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies. Crit Rev Oncol Hematol. 2013;88:187–97.
Article
CAS
PubMed
Google Scholar
Schneider R. Comparison of age, sex, and incidence rates in human and canine breast cancer. Cancer. 1970;26:419–26.
Article
CAS
PubMed
Google Scholar
Pinho SS, Carvalho S, Cabral J, Reis CA, Gärtner F. Canine tumors: a spontaneous animal model of human carcinogenesis. Transl Res. 2012;159:165–72.
Article
PubMed
Google Scholar
Page R, Baneux P, Vail D, Duda L, Olson P, Anestidou L, Dybdal N, Golab G, Shelton W, Salgaller M, Hardy C. Conduct, oversight, and ethical considerations of clinical trials in companion animals with cancer: report of a workshop on best practice recommendations. J Vet Intern Med. 2016;30:527–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros MSF, Swaminathan R, Ferlay J. Cancer incidence in five continents, vol. X. IARC Scientific Publication No. 164. Lyon: International Agency for Research on Cancer; 2014.
Google Scholar
Parkin DM, Ferlay J, Curado M-P, Bray F, Edwards B, Shin H-R, Forman D. Fifty years of cancer incidence: CI5 I-IX. Int J Cancer. 2010;127:2918–27.
Article
CAS
PubMed
Google Scholar
Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer. 2009;125:229–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.
Article
PubMed
Google Scholar
Dorfman HD, Czerniak B. Bone cancers. Cancer. 1995;75:203–10.
Article
CAS
PubMed
Google Scholar
Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer. 2009;115:1531–43.
Article
PubMed
PubMed Central
Google Scholar
Egenvall A, Nødtvedt A, von Euler H. Bone tumors in a population of 400 000 insured Swedish dogs up to 10 y of age: incidence and survival. Can J Vet Res. 2007;71:292–9.
PubMed
PubMed Central
Google Scholar
Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8–29.
Article
PubMed
Google Scholar
Anfinsen KP, Grotmol T, Bruland OS, Jonasdottir TJ. Breed-specific incidence rates of canine primary bone tumors—a population based survey of dogs in norway. Can J Vet Res. 2011;75:209–15.
PubMed
PubMed Central
Google Scholar
Sapierzynski R, Czopowicz M. The animal-dependent risk factors in canine osteosarcomas. Pol J Vet Sci. 2017;20:293–8.
CAS
PubMed
Google Scholar
Souhami R, Tobias J, editors. Bone and soft-tissue sarcomas. In: Cancer and its management. Chichester: Blackwell Publishing Ltd; 2005. p. 386–404.
Klein MJ, Siegal GP. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol. 2006;125:555–81.
Article
PubMed
Google Scholar
Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. Who classification of tumours of soft tissue and bone. 4th ed. Geneva: WHO Press; 2013.
Google Scholar
Slayter MV, Boosinger TR, Pool RR, Dammrich K, Misdrop W, Larsen S, World Health Organization. International histologic classification of tumors of domestic animals, histological classification of bone and joint tumors of domestic animals. Washington, DC: Armed Forces Institute of Pathology American Registry of Pathology; 1994.
Google Scholar
Nagamine E, Hirayama K, Matsuda K, Okamoto M, Ohmachi T, Kadosawa T, Taniyama H. Diversity of histologic patterns and expression of cytoskeletal proteins in canine skeletal osteosarcoma. Vet Pathol. 2015;52:977–84.
Article
CAS
PubMed
Google Scholar
Fenger JM, London CA, Kisseberth WC. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology. ILAR J. 2014;55:69–85.
Article
CAS
PubMed
Google Scholar
Loukopoulos P, Robinson WF. Clinicopathological relevance of tumour grading in canine osteosarcoma. J Comp Pathol. 2007;136:65–73.
Article
CAS
PubMed
Google Scholar
Righi A, Paioli A, Dei Tos AP, Gambarotti M, Palmerini E, Cesari M, Marchesi E, Donati DM, Picci P, Ferrari S. High-grade focal areas in low-grade central osteosarcoma: high-grade or still low-grade osteosarcoma? Clin Sarcoma Res. 2015;5:23.
Article
PubMed
PubMed Central
Google Scholar
Withrow SJ, Wilkins RM. Cross talk from pets to people: translational osteosarcoma treatments. ILAR J. 2010;51:208–13.
Article
CAS
PubMed
Google Scholar
Kirpensteijn J, Kik M, Rutteman GR, Teske E. Prognostic significance of a new histologic grading system for canine osteosarcoma. Vet Pathol. 2002;39:240–6.
Article
CAS
PubMed
Google Scholar
Kruse MA, Holmes ES, Balko JA, Fernandez S, Brown DC, Goldschmidt MH. Evaluation of clinical and histopathologic prognostic factors for survival in canine osteosarcoma of the extracranial flat and irregular bones. Vet Pathol. 2013;50:704–8.
Article
CAS
PubMed
Google Scholar
Morello E, Martano M, Buracco P. Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma. Vet J. 2011;189:268–77.
Article
PubMed
Google Scholar
Selmic LE, Burton JH, Thamm DH, Withrow SJ, Lana SE. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. J Vet Intern Med. 2014;28:554–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ta HT, Dass CR, Choong PFM, Dunstan DE. Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 2009;28:247–63.
Article
PubMed
Google Scholar
Liptak JM, Dernell WS, Ehrhart N, Lafferty MH, Monteith GJ, Withrow SJ. Cortical allograft and endoprosthesis for limb-sparing surgery in dogs with distal radial osteosarcoma: a prospective clinical comparison of two different limb-sparing techniques. Vet Surg. 2006;35:518–33.
Article
PubMed
Google Scholar
Reddy KIA, Wafa H, Gaston CL, Grimer RJ, Abudu AT, Jeys LM, Carter SR, Tillman RM. Does amputation offer any survival benefit over limb salvage in osteosarcoma patients with poor chemonecrosis and close margins? Bone Joint J. 2015;97(B):115–20.
Article
PubMed
Google Scholar
Mavrogenis A, Abati C, Romagnoli C, Ruggieri P. Similar survival but better function for patients after limb salvage versus amputation for distal tibia osteosarcoma. Clin Orthop Relat Res. 2012;470:1735–48.
Article
PubMed
PubMed Central
Google Scholar
Li X, Zhang Y, Wan S, Li H, Li D, Xia J, Yuan Z, Ren M, Yu S, Li S, et al. A comparative study between limb-salvage and amputation for treating osteosarcoma. J Bone Oncol. 2016;5:15–21.
Article
PubMed
PubMed Central
Google Scholar
Mitchell KE, Boston SE, Kung M, Dry S, Straw RC, Ehrhart NP, Ryan SD. Outcomes of limb-sparing surgery using two generations of metal endoprosthesis in 45 dogs with distal radial osteosarcoma. A veterinary society of surgical oncology retrospective study. Vet Surg. 2016;45:36–43.
Article
PubMed
Google Scholar
Lascelles BD, Dernell WS, Correa MT, Lafferty M, Devitt CM, Kuntz CA, Straw RC, Withrow SJ. Improved survival associated with postoperative wound infection in dogs treated with limb-salvage surgery for osteosarcoma. Ann Surg Oncol. 2005;12:1073–83.
Article
PubMed
Google Scholar
Culp WT, Olea-Popelka F, Sefton J, Aldridge CF, Withrow SJ, Lafferty MH, Rebhun RB, Kent MS, Ehrhart N. Evaluation of outcome and prognostic factors for dogs living greater than one year after diagnosis of osteosarcoma: 90 cases (1997–2008). J Am Vet Med Assoc. 2014;245:1141–6.
Article
PubMed
PubMed Central
Google Scholar
Sottnik JL, U’Ren LW, Thamm DH, Withrow SJ, Dow SW. Chronic bacterial osteomyelitis suppression of tumor growth requires innate immune responses. Cancer Immunol Immunother. 2010;59:367–78.
Article
CAS
PubMed
Google Scholar
Seo K, Holt R, Jung YS, Rodriguez CO Jr, Chen X, Rebhun RB. Fluoroquinolone-mediated inhibition of cell growth, S-G2/M cell cycle arrest, and apoptosis in canine osteosarcoma cell lines. PLoS ONE. 2012;7:e42960.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jeys LM, Grimer RJ, Carter SR, Tillman RM, Abudu A. Post operative infection and increased survival in osteosarcoma patients: are they associated? Ann Surg Oncol. 2007;14:2887–95.
Article
CAS
PubMed
Google Scholar
Chen YU, Xu SF, Xu M, Yu XC. Postoperative infection and survival in osteosarcoma patients: reconsideration of immunotherapy for osteosarcoma. Mol Clin Oncol. 2015;3:495–500.
Article
CAS
PubMed
PubMed Central
Google Scholar
Anderson ME. Update on survival in osteosarcoma. Orthop Clin North Am. 2016;47:283–92.
Article
PubMed
Google Scholar
Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment—where do we stand? A state of the art review. Cancer Treat Rev. 2014;40:523–32.
Article
PubMed
Google Scholar
Winkler K, Bielack SS, Delling G, Jurgens H, Kotz R, Salzer-Kuntschik M. Treatment of osteosarcoma: experience of the cooperative osteosarcoma study group (COSS). Cancer Treat Res. 1993;62:269–77.
Article
CAS
PubMed
Google Scholar
Zhang FY, Tang W, Zhang ZZ, Huang JC, Zhang SX, Zhao XC. Systematic review of high-dose and standard-dose chemotherapies in the treatment of primary well-differentiated osteosarcoma. Tumour Biol. 2014;35:10419–27.
Article
CAS
PubMed
Google Scholar
Ferrari S, Serra M. An update on chemotherapy for osteosarcoma. Expert Opin Pharmacother. 2015;16:2727–36.
Article
CAS
PubMed
Google Scholar
Wang WG, Wan C, Liao GJ. The efficacy of high-dose versus moderate-dose chemotherapy in treating osteosarcoma: a systematic review and meta-analysis. Int J Clin Exp Med. 2015;8:15967–74.
PubMed
PubMed Central
Google Scholar
Fan XL, Cai GP, Zhu LL, Ding GM. Efficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysis. Drug Des Dev Ther. 2015;9:5925–32.
Article
Google Scholar
Su W, Lai Z, Wu F, Lin Y, Mo Y, Yang Z, Wu J. Clinical efficacy of preoperative chemotherapy with or without ifosfamide in patients with osteosarcoma of the extremity: meta-analysis of randomized controlled trials. Med Oncol. 2015;32:481.
Article
PubMed
CAS
Google Scholar
Skorupski KA, Uhl JM, Szivek A, Allstadt Frazier SD, Rebhun RB, Rodriguez CO Jr. Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase iii trial. Vet Comp Oncol. 2016;14:81–7.
Article
CAS
PubMed
Google Scholar
Berg J. Canine osteosarcoma: amputation and chemotherapy. Vet Clin North Am Small Anim Pract. 1996;26:111–21.
Article
CAS
PubMed
Google Scholar
Phillips B, Powers BE, Dernell WS, Straw RC, Khanna C, Hogge GS, Vail DM. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs. J Am Anim Hosp Assoc. 2009;45:33–8.
Article
PubMed
Google Scholar
Saam DE, Liptak JM, Stalker MJ, Chun R. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996–2006). J Am Vet Med Assoc. 2011;238:195–206.
Article
PubMed
Google Scholar
Alvarez FJ, Kisseberth W, Hosoya K, Lara-Garcia A, Kosarek C, Murahari S, Au JL, Wientjes MG, Couto J, Couto G. Postoperative adjuvant combination therapy with doxorubicin and noncytotoxic suramin in dogs with appendicular osteosarcoma. J Am Anim Hosp Assoc. 2014;50:12–8.
Article
PubMed
Google Scholar
Kent MS, Strom A, London CA, Seguin B. Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing surgery in the treatment of appendicular osteosarcoma in dogs. J Vet Intern Med. 2004;18:540–4.
Article
PubMed
Google Scholar
Bacon NJ, Ehrhart NP, Dernell WS, Lafferty M, Withrow SJ. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999–2006). J Am Vet Med Assoc. 2008;232:1504–10.
Article
CAS
PubMed
Google Scholar
McMahon M, Mathie T, Stingle N, Romansik E, Vail D, London C. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma. J Vet Intern Med. 2011;25:511–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Evdokiou A, Labrinidis A, Bouralexis S, Hay S, Findlay DM. Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis. Bone. 2003;33:216–28.
Article
CAS
PubMed
Google Scholar
Horie N, Murata H, Kimura S, Takeshita H, Sakabe T, Matsui T, Maekawa T, Kubo T, Fushiki S. Combined effects of a third-generation bisphosphonate, zoledronic acid with other anticancer agents against murine osteosarcoma. Br J Cancer. 2007;96:255–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zekri J, Mansour M, Karim SM. The anti-tumour effects of zoledronic acid. J Bone Oncol. 2014;3:25–35.
Article
PubMed
PubMed Central
Google Scholar
Ohba T, Cates JM, Cole HA, Slosky DA, Haro H, Ichikawa J, Ando T, Schwartz HS, Schoenecker JG. Pleiotropic effects of bisphosphonates on osteosarcoma. Bone. 2014;63:110–20.
Article
CAS
PubMed
Google Scholar
Wu CC, Huang YF, Hsieh CP, Chueh PJ, Chen YL. Combined use of zoledronic acid augments ursolic acid-induced apoptosis in human osteosarcoma cells through enhanced oxidative stress and autophagy. Molecules. 2016;21(12):1640.
Article
CAS
Google Scholar
Endo-Munoz L, Cumming A, Rickwood D, Wilson D, Cueva C, Ng C, Strutton G, Cassady AI, Evdokiou A, Sommerville S, et al. Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases. Cancer Res. 2010;70:7063–72.
Article
CAS
PubMed
Google Scholar
Wolfe TD, Pillai SPS, Hildreth BE, Lanigan LG, Martin CK, Werbeck JL, Rosol TJ. Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice. Clin Exp Metastasis. 2011;28:377–89.
Article
CAS
PubMed
PubMed Central
Google Scholar
Piperno-Neumann S, Le Deley MC, Redini F, Pacquement H, Marec-Berard P, Petit P, Brisse H, Lervat C, Gentet JC, Entz-Werle N, et al. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (os2006): a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol. 2016;17:1070–80.
Article
CAS
PubMed
Google Scholar
Koto K, Horie N, Kimura S, Murata H, Sakabe T, Matsui T, Watanabe M, Adachi S, Maekawa T, Fushiki S, Kubo T. Clinically relevant dose of zoledronic acid inhibits spontaneous lung metastasis in a murine osteosarcoma model. Cancer Lett. 2009;274:271–8.
Article
CAS
PubMed
Google Scholar
Conry RM, Rodriguez MG, Pressey JG. Zoledronic acid in metastatic osteosarcoma: encouraging progression free survival in four consecutive patients. Clin Sarcoma Res. 2016;6:6.
Article
PubMed
PubMed Central
CAS
Google Scholar
Byrum ML, Pondenis HC, Fredrickson RL, Wycislo KL, Fan TM. Downregulation of CXCR4 expression and functionality after zoledronate exposure in canine osteosarcoma. J Vet Intern Med. 2016;30:1187–96.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mason NJ, Gnanandarajah JS, Engiles JB, Gray F, Laughlin D, Gaurnier-Hausser A, Wallecha A, Huebner M, Paterson Y. Immunotherapy with a HER2-targeting listeria induces HER2-specific immunity and demonstrates potential therapeutic effects in a phase i trial in canine osteosarcoma. Clin Cancer Res. 2016;22:4380–90.
Article
CAS
PubMed
Google Scholar
Bishop MW, Janeway KA, Gorlick R. Future directions in the treatment of osteosarcoma. Curr Opin Pediatr. 2016;28:26–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wan J, Zhang X, Liu T. Strategies and developments of immunotherapies in osteosarcoma. Oncol Lett. 2016;11:511–20.
PubMed
Google Scholar
Botter SM, Neri D, Fuchs B. Recent advances in osteosarcoma. Curr Opin Pharmacol. 2014;16:15–23.
Article
CAS
PubMed
Google Scholar
Murakami T, Igarashi K, Kawaguchi K, Kiyuna T, Zhang Y, Zhao M, Hiroshima Y, Nelson SD, Dry SM, Li Y, et al. Tumor-targeting salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drug. Oncotarget. 2017;8:8035–42.
PubMed
Google Scholar
Bielack SS, Hecker-Nolting S, Blattmann C, Kager L. Advances in the management of osteosarcoma. F1000Research. 2016;5:2767.
Article
PubMed
PubMed Central
Google Scholar
Shapiro W, Fossum TW, Kitchell BE, Couto CG, Theilen GH. Use of cisplatin for treatment of appendicular osteo-sarcoma in dogs. J Am Vet Med Assoc. 1988;192:507–11.
CAS
PubMed
Google Scholar
Thompson JP, Fugent MJ. Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs—30 cases (1979–1990). J Am Vet Med Assoc. 1992;200:531–3.
CAS
PubMed
Google Scholar
MacEwen EG, Kurzman ID. Canine osteosarcoma: amputation and chemoimmunotherapy. Vet Clin North Am Small Anim Pract. 1996;26:123–33.
Article
CAS
PubMed
Google Scholar
Serra M, Hattinger CM. The pharmacogenomics of osteosarcoma. Pharmacogenomics J. 2017;17:11–20.
Article
CAS
PubMed
Google Scholar
Vos HI, Coenen MJ, Guchelaar HJ, Te Loo DM. The role of pharmacogenetics in the treatment of osteosarcoma. Drug Discov Today. 2016;21:1775–86.
Article
CAS
PubMed
Google Scholar
Bacci G, Rocca M, Salone M, Balladelli A, Ferrari S, Palmerini E, Forni C, Briccoli A. High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol. 2008;98:415–20.
Article
PubMed
Google Scholar
Frimberger AE, Chan CM, Moore AS. Canine osteosarcoma treated by post-amputation sequential accelerated doxorubicin and carboplatin chemotherapy: 38 cases. J Am Anim Hosp Assoc. 2016;52:149–56.
Article
PubMed
Google Scholar
Moore AS, Dernell WS, Ogilvie GK, Kristal O, Elmslie R, Kitchell B, Susaneck S, Rosenthal R, Klein MK, Obradovoich J, et al. Doxorubicin and bay 12–9566 for the treatment of osteosarcoma in dogs: a randomized, double-blind, placebo-controlled study. J Vet Intern Med. 2007;21:783–90.
Article
PubMed
Google Scholar
Straw RC, Withrow SJ, Richter SL, Powers BE, Klein MK, Postorino NC, LaRue SM, Ogilvie GK, Vail DM, Morrison WB, et al. Amputation and cisplatin for treatment of canine osteosarcoma. J Vet Intern Med. 1991;5:205–10.
Article
CAS
PubMed
Google Scholar
Thomas R, Wang HJ, Tsai PC, Langford CF, Fosmire SP, Jubala CM, Getzy DM, Cutter GR, Modiano JF, Breen M. Influence of genetic background on tumor karyotypes: evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma. Chromosome Res. 2009;17:365–77.
Article
CAS
PubMed
PubMed Central
Google Scholar
Angstadt AY, Motsinger-Reif A, Thomas R, Kisseberth WC, Guillermo Couto C, Duval DL, Nielsen DM, Modiano JF, Breen M. Characterization of canine osteosarcoma by array comparative genomic hybridization and Rt-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart. Gene Chromosome Cancer. 2011;50:859–74.
Article
CAS
Google Scholar
Bergman PJ, MacEwen EG, Kurzman ID, Henry CJ, Hammer AS, Knapp DW, Hale A, Kruth SA, Klein MK, Klausner J, et al. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993). J Vet Intern Med. 1996;10:76–81.
Article
CAS
PubMed
Google Scholar
Amsellem PM, Selmic LE, Wypij JM, Bacon NJ, Culp WT, Ehrhart NP, Powers BE, Stryhn H, Farese JP. Appendicular osteosarcoma in small-breed dogs: 51 cases (1986–2011). J Am Vet Med Assoc. 2014;245:203–10.
Article
PubMed
Google Scholar
Boerman I, Selvarajah GT, Nielen M, Kirpensteijn J. Prognostic factors in canine appendicular osteosarcoma—a meta-analysis. BMC Vet Res. 2012;8:56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Garzotto CK, Berg J, Hoffmann WE, Rand WM. Prognostic significance of serum alkaline phosphatase activity in canine appendicular osteosarcoma. J Vet Intern Med. 2000;14:587–92.
Article
CAS
PubMed
Google Scholar
Wilson H, Huelsmeyer M, Chun R, Young KM, Friedrichs K, Argyle DJ. Isolation and characterisation of cancer stem cells from canine osteosarcoma. Vet J. 2008;175:69–75.
Article
CAS
PubMed
Google Scholar
Zhang Q, Liu F, Wang B, Li Z, Zhou D, Yang Q, Dong J, Li J. HER-2 expression in biopsy and surgical specimen on prognosis of osteosarcoma: a systematic review and meta-analysis of 16 studies. Medicine (Baltimore). 2016;95:e3661.
Article
CAS
Google Scholar
Gill J, Geller D, Gorlick R. HER-2 involvement in osteosarcoma. Adv Exp Med Biol. 2014;804:161–77.
Article
CAS
PubMed
Google Scholar
Baumhoer D, Smida J, Specht K, Bink K, Quintanilla-Martinez L, Rosemann M, Siggelkow H, Nathrath WB, Atkinson MJ, Bielack S, et al. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma. Hum Pathol. 2011;42:859–66.
Article
CAS
PubMed
Google Scholar
Selvarajah GT, Verheije MH, Kik M, Slob A, Rottier PJM, Mol JA, Kirpensteijn J. Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis. Vet J. 2012;193:412–9.
Article
PubMed
Google Scholar
Yu XW, Wu TY, Yi X, Ren WP, Zhou ZB, Sun YQ, Zhang CQ. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis. Tumour Biol. 2014;35:155–60.
Article
CAS
PubMed
Google Scholar
Qu JT, Wang M, He HL, Tang Y, Ye XJ. The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review. J Cancer Res Clin Oncol. 2012;138:819–25.
Article
CAS
PubMed
Google Scholar
Fu HL, Shao L, Wang Q, Jia T, Li M, Yang DP. A systematic review of p53 as a biomarker of survival in patients with osteosarcoma. Tumour Biol. 2013;34:3817–21.
Article
CAS
PubMed
Google Scholar
Kirpensteijn J, Kik M, Teske E, Rutteman GR. TP53 gene mutations in canine osteosarcoma. Vet Surg. 2008;37:454–60.
Article
PubMed
Google Scholar
Sarver AL, Thayanithy V, Scott MC, Cleton-Jansen AM, Hogendoorn PC, Modiano JF, Subramanian S. Micrornas at the human 14q32 locus have prognostic significance in osteosarcoma. Orphanet J Rare Dis. 2013;8:7.
Article
PubMed
PubMed Central
Google Scholar
Jaroensong T, Endo Y, Lee SJ, Kamida A, Mochizuki M, Nishimura R, Sasaki N, Nakagawa T. Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice. Vet Comp Oncol. 2012;10:274–82.
Article
CAS
PubMed
Google Scholar
Ren L, Hong SH, Chen QR, Briggs J, Cassavaugh J, Srinivasan S, Lizardo MM, Mendoza A, Xia AY, Avadhani N, et al. Dysregulation of ezrin phosphorylation prevents metastasis and alters cellular metabolism in osteosarcoma. Cancer Res. 2012;72:1001–12.
Article
CAS
PubMed
Google Scholar
Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med. 2004;10:182–6.
Article
CAS
PubMed
Google Scholar
Xu-Dong S, Zan S, Shui-er Z, Li-na T, Wen-xi Y, Feng L, Yang Y. Expression of ezrin correlates with lung metastasis in Chinese patients with osteosarcoma. Clin Invest Med. 2009;32:E180–8.
Article
PubMed
Google Scholar
McManus M, Kleinerman E, Yang Y, Livingston JA, Mortus J, Rivera R, Zweidler-McKay P, Schadler K. Hes4: A potential prognostic biomarker for newly diagnosed patients with high-grade osteosarcoma. Pediatr Blood Cancer. 2016. doi:10.1002/pbc.26318.
PubMed
Google Scholar
Fieten H, Spee B, Ijzer J, Kik MJ, Penning LC, Kirpensteijn J. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma. Vet Pathol. 2009;46:869–77.
Article
CAS
PubMed
Google Scholar
Ognjanovic S, Olivier M, Bergemann TL, Hainaut P. Sarcomas in tp53 germline mutation carriers. Cancer. 2012;118:1387–96.
Article
CAS
PubMed
Google Scholar
Stinco G, Governatori G, Mattighello P, Patrone P. Multiple cutaneous neoplasms in a patient with Rothmund–Thomson syndrome: case report and published work review. J Dermatol. 2008;35:154–61.
Article
PubMed
Google Scholar
Thomas DM, Ballinger ML. Etiologic, environmental and inherited risk factors in sarcomas. J Surg Oncol. 2015;111:490–5.
Article
PubMed
Google Scholar
Mirabello L, Pfeiffer R, Murphy G, Daw NC, Patiño-Garcia A, Troisi RJ, Hoover RN, Douglass C, Schüz J, Craft AW, Savage SA. Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes Control. 2011;22:899–908.
Article
PubMed
PubMed Central
Google Scholar
Savage SA, Mirabello L, Wang Z, Gastier-Foster JM, Gorlick R, Khanna C, Flanagan AM, Tirabosco R, Andrulis IL, Wunder JS, et al. Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nature Genet. 2013;45:799–803.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, Nyholt DR, Madden PA, Heath AC, Martin NG, Montgomery GW, et al. Common SNPs explain a large proportion of the heritability for human height. Nature Genet. 2010;42:565–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen X, Bahrami A, Pappo A, Easton J, Dalton J, Hedlund E, Ellison D, Shurtleff S, Wu G, Wei L, et al. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep. 2014;7:104–12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-fraumeni syndrome. Nature. 1990;348:747–9.
Article
CAS
PubMed
Google Scholar
Zhang J, Walsh MF, Wu G, Edmonson MN, Gruber TA, Easton J, Hedges D, Ma X, Zhou X, Yergeau DA, et al. Germline mutations in predisposition genes in pediatric cancer. N Engl J Med. 2015;373:2336–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Poos K, Smida J, Nathrath M, Maugg D, Baumhoer D, Neumann A, Korsching E. Structuring osteosarcoma knowledge: An osteosarcoma-gene association database based on literature mining and manual annotation. Database. 2014. doi:10.1093/database/bau042.
PubMed
PubMed Central
Google Scholar
Man T-K, Lu X-Y, Jaeweon K, Perlaky L, Harris CP, Shah S, Ladanyi M, Gorlick R, Lau CC, Rao PH. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer. 2004;4:45.
Article
PubMed
PubMed Central
CAS
Google Scholar
Xiao X, Wang W, Zhang H, Gao P, Fan B, Huang C, Fu J, Chen G, Shi L, Zhu H, et al. Individualized chemotherapy for osteosarcoma and identification of gene mutations in osteosarcoma. Tumour Biol. 2015;36:2427–35.
Article
CAS
PubMed
Google Scholar
Yuan D, Liu B, Liu K, Zhu G, Dai Z, Xie Y. Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma. J Surg Oncol. 2013;108:157–62.
Article
CAS
PubMed
Google Scholar
de Bruin EC, McGranahan N, Mitter R, Salm M, Wedge DC, Yates L, Jamal-Hanjani M, Shafi S, Murugaesu N, Rowan AJ, et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science. 2014;346:251–6.
Article
PubMed
PubMed Central
CAS
Google Scholar
Galanos P, Vougas K, Walter D, Polyzos A, Maya-Mendoza A, Haagensen EJ, Kokkalis A, Roumelioti F-M, Gagos S, Tzetis M, et al. Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing. Nat Cell Biol. 2016;18:777–89.
CAS
PubMed
Google Scholar
Al-Romaih K, Bayani J, Vorobyova J, Karaskova J, Park PC, Zielenska M, Squire JA. Chromosomal instability in osteosarcoma and its association with centrosome abnormalities. Cancer Genet Cytogenet. 2003;144:91–9.
Article
CAS
PubMed
Google Scholar
Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nature Genet. 2006;38:1043–8.
Article
CAS
PubMed
Google Scholar
Ru G, Terracini B, Glickman LT. Host related risk factors for canine osteosarcoma. Vet J. 1998;156:31–9.
Article
CAS
PubMed
Google Scholar
Phillips JC, Stephenson B, Hauck M, Dillberger J. Heritability and segregation analysis of osteosarcoma in the Scottish deerhound. Genomics. 2007;90:354–63.
Article
CAS
PubMed
Google Scholar
von Holdt BM, Pollinger JP, Lohmueller KE, Han E, Parker HG, Quignon P, Degenhardt JD, Boyko AR, Earl DA, Auton A, et al. Genome-wide SNP and haplotype analyses reveal a rich history underlying dog domestication. Nature. 2010;464:898–902.
Article
CAS
Google Scholar
Caro JT, Marin LM, Iazbik MC, Zaldivar-Lopez S, Borghese H, Couto CG. Markers of iron metabolism in retired racing greyhounds with and without osteosarcoma. Vet Clin Pathol. 2013;42:360–3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lord LK, Yaissle JE, Marin L, Couto CG. Results of a web-based health survey of retired racing greyhounds. J Vet Intern Med. 2007;21:1243–50.
Article
PubMed
Google Scholar
Samaha J. The new complete Irish wolfhound. Howell Book House; 1991.
Philipp U, Vollmar A, Häggström J, Thomas A, Distl O. Multiple loci are associated with dilated cardiomyopathy in Irish wolfhounds. PLoS ONE. 2012;7:e36691.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jansson M, Laikre L. Recent breeding history of dog breeds in Sweden: modest rates of inbreeding, extensive loss of genetic diversity and lack of correlation between inbreeding and health. J Anim Breed Genet. 2014;131:153–62.
Article
CAS
PubMed
Google Scholar
The Kennel Club UK. Breed information centre—rottweiler. 2016. http://www.thekennelclub.org.uk/services/public/breed/display.aspx?id=5137. Accessed 29 Aug 2017.
American Kennel Club. Rottweiler. 2017. http://www.akc.org/dog-breeds/rottweiler/. Accessed 28 Aug 2017.
Karlsson EK, Sigurdsson S, Ivansson E, Thomas R, Elvers I, Wright J, Howald C, Tonomura N, Perloski M, Swofford R, et al. Genome-wide analyses implicate 33 loci in heritable dog osteosarcoma, including regulatory variants near CDKN2A/B. Genome Biol. 2013;14:R132.
Article
PubMed
PubMed Central
CAS
Google Scholar
Phillips JC, Lembcke L, Chamberlin T. A novel locus for canine osteosarcoma (OSA1) maps to CFA34, the canine orthologue of human 3q26. Genomics. 2010;96:220–7.
Article
CAS
PubMed
Google Scholar
Dobson JM. Breed-predispositions to cancer in pedigree dogs. ISRN Vet Sci. 2013;2013:941275.
Article
PubMed
PubMed Central
CAS
Google Scholar
MacEwen EG, Pastor J, Kutzke J, Tsan R, Kurzman ID, Thamm DH, Wilson M, Radinsky R. IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma. J Cell Biochem. 2004;92:77–91.
Article
CAS
PubMed
Google Scholar
McCleese JK, Bear MD, Kulp SK, Mazcko C, Khanna C, London CA. Met interacts with EGFR and Ron in canine osteosarcoma. Vet Comp Oncol. 2013;11:124–39.
Article
CAS
PubMed
Google Scholar
Millanta F, Asproni P, Cancedda S, Vignoli M, Bacci B, Poli A. Immunohistochemical expression of COX-2, mPGES and EP2 receptor in normal and reactive canine bone and in canine osteosarcoma. J Comp Pathol. 2012;147:153–60.
Article
CAS
PubMed
Google Scholar
Pang LY, Argyle SA, Kamida A, Morrison K, Argyle DJ. The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells. BMC Vet Res. 2014;10:184.
PubMed
PubMed Central
Google Scholar
Shahi MH, York D, Gandour-Edwards R, Withers SS, Holt R, Rebhun RB. BMI1 is expressed in canine osteosarcoma and contributes to cell growth and chemotherapy resistance. PLoS ONE. 2015;10:e0131006.
Article
PubMed
PubMed Central
CAS
Google Scholar
Maniscalco L, Iussich S, Morello E, Martano M, Gattino F, Miretti S, Biolatti B, Accornero P, Martignani E, Sánchez-Céspedes R, et al. Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma. Vet J. 2015;205:272–80.
Article
CAS
PubMed
Google Scholar
Selvarajah GT, Kirpensteijn J, van Wolferen ME, Rao NAS, Fieten H, Mol JA. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times. Mol Cancer. 2009;8:72.
Article
PubMed
PubMed Central
CAS
Google Scholar
Selvarajah GT, Bonestroo FAS, Kirpensteijn J, Kik MJL, van der Zee R, van Eden W, Timmermans-Sprang EPM, Slob A, Mol JA. Heat shock protein expression analysis in canine osteosarcoma reveals HSP60 as a potentially relevant therapeutic target. Cell Stress Chaperon. 2013;18:607–22.
Article
CAS
Google Scholar